Brief: Sanofi Expects Moderate Increases In R&D Spend
30/07/2026 13:42
BRIEF-Sanofi Expects Moderate Increases In R&D Spend July 30 (Reuters) - Sanofi SA SASY.PA:
SANOFI CEO BELEN GARIJO SAYS EXPECT TO HAVE MODERATE INCREASES IN OUR RESEARCH AND DEVELOPMENT SPEND IN THE MID TERM - ANALYST CALL
SANOFI CEO SAYS "WE HAVE TO CATCH UP AND BENEFIT FROM THE WAVE OF INNOVATION THAT IS EMERGING IN CHINA"
SANOFI CEO SAYS CO'S STRATEGY IN CHINA MAY NOT BE COMPLETELY MIRRORING SANOFI'S GLOBAL STRATEGY
SANOFI CEO SAYS REGENERON PARTNERSHIP NOT A BARRIER TO MOVING FORWARD WITH M&A
SANOFI EXEC SAYS EXPECT DUPIXENT PATENT TO BE PROTECTED BEYOND MARCH 2031 - ANALYST CALL
Further company coverage: SASY.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sanofi SA
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
EdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments